China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
China NT Pharma Group Co., Ltd. has announced that all resolutions presented at its Annual General Meeting on June 28, 2024, were passed with overwhelming support from shareholders. Key resolutions included the adoption of financial statements, re-election of directors, and granting of general mandates for share allocation and repurchase. The meeting, overseen by Chairman Mr. Ng Tit, marked a unanimous agreement on the proposed agendas, showcasing strong shareholder confidence in the company’s corporate governance.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.
